Nanoparticle hydrophobicity dictates immune response.

Understanding the interactions of nanomaterials with the immune system is essential for the engineering of new macromolecular systems for in vivo applications. Systematic study of immune activation is challenging due to the complex structure of most macromolecular probes. We present here the use of engineered gold nanoparticles to determine the sole effect of hydrophobicity on the immune response of splenocytes. The gene expression profile of a range of cytokines (immunological reporters) was analyzed against the calculated log P of the nanoparticle headgroups, with an essentially linear increase in immune activity with the increase in hydrophobicity observed in vitro. Consistent behavior was observed with in vivo mouse models, demonstrating the importance of hydrophobicity in immune system activation.

[1]  Polly Matzinger,et al.  Tissue-based class control: the other side of tolerance , 2011, Nature Reviews Immunology.

[2]  A. Tropsha,et al.  Quantitative nanostructure-activity relationship modeling. , 2010, ACS nano.

[3]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[4]  Vincent M. Rotello,et al.  Enzyme-amplified array sensing of proteins in solution and in biofluids. , 2010, Journal of the American Chemical Society.

[5]  Vincent M Rotello,et al.  Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish. , 2010, Small.

[6]  V. Rotello,et al.  Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.

[7]  Younan Xia,et al.  Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. , 2009, Nano letters.

[8]  K. Wynne,et al.  Water-induced surface rearrangements of poly(dimethylsiloxane-urea-urethane) segmented block copolymers , 1996 .

[9]  Neetu Singh,et al.  Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.

[10]  Robert J. Lefkowitz,et al.  Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[12]  B. Beutler,et al.  The evolution and genetics of innate immunity , 2001, Nature Reviews Genetics.

[13]  Vincent M Rotello,et al.  Nano meets biology: structure and function at the nanoparticle interface. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[14]  Polly Matzinger,et al.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.

[15]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[16]  T. Puzyn,et al.  Toward the development of "nano-QSARs": advances and challenges. , 2009, Small.

[17]  Jerzy Leszczynski,et al.  Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. , 2011, Nature nanotechnology.

[18]  M. Akashi,et al.  Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. , 2007, Biomaterials.

[19]  D. Peer,et al.  Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target , 2008, Science.

[20]  Dan Peer,et al.  The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. , 2010, Biomaterials.

[21]  D. Peer,et al.  Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Mark E. Davis,et al.  Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.

[23]  Allan S. Hoffman,et al.  The origins and evolution of "controlled" drug delivery systems. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Robert Langer,et al.  Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.

[25]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[26]  Ravi Kumar M.N.V..  Nano and microparticles as controlled drug delivery devices. , 2000 .

[27]  J. Ruysschaert,et al.  Cationic liposomal lipids: from gene carriers to cell signaling. , 2008, Progress in lipid research.

[28]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[29]  Subinoy Rana,et al.  Gold nanoparticle-polymer/biopolymer complexes for protein sensing. , 2011, Faraday discussions.

[30]  G. Rose,et al.  Hydrogen bonding, hydrophobicity, packing, and protein folding. , 1993, Annual review of biophysics and biomolecular structure.

[31]  Jerzy Leszczynski,et al.  Predicting water solubility and octanol water partition coefficient for carbon nanotubes based on the chiral vector , 2007, Comput. Biol. Chem..

[32]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[33]  Zhiguang Li,et al.  A Myeloid Cell Population Induced by Freund Adjuvant Suppresses T-cell−mediated Antitumor Immunity , 2010, Journal of immunotherapy.

[34]  F. He,et al.  Cationic lipids enhance siRNA-mediated interferon response in mice. , 2005, Biochemical and biophysical research communications.

[35]  C. Mirkin,et al.  Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates. , 2009, Molecular pharmaceutics.

[36]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[37]  C. Janeway,et al.  Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54: 1-13. , 2013, Journal of immunology.

[38]  A. Iwasaki,et al.  Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.

[39]  K. Rock,et al.  How dying cells alert the immune system to danger , 2008, Nature Reviews Immunology.

[40]  R. Lempicki,et al.  Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like Particles , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[41]  Hak Soo Choi,et al.  Design considerations for tumour-targeted nanoparticles. , 2010, Nature nanotechnology.

[42]  Jim E Riviere,et al.  An index for characterization of nanomaterials in biological systems. , 2010, Nature nanotechnology.

[43]  G. Somorjai,et al.  Detection of Hydrophobic End Groups on Polymer Surfaces by Sum-Frequency Generation Vibrational Spectroscopy , 2000 .